Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.

Although the 17% absolute difference in survival rate between the groups did not reach statistical significance ( p = 0.0874), that difference in mortality rate is clinically meaningful, since there were about half as many deaths (18% versus 35%) when raxibacumab was administered.

also in 111,027 other papers